Laura Barreto, Certified PoNS™ Trainer, speaks about PoNS Treatment™
Marcos Rodrigues, Certified PoNS™ Trainer, shares some of his experience with PoNS™
Melissa Medeiros, Occupational Therapist, talks about her PoNS treatment™ experience
Kim Skinner, lead physiotherapist in the clinical trials talks about her patients
As the lead physiotherapist involved in the clinical trials, I saw firsthand some of the most impactful and meaningful changes that participants experienced. As a result of improvements in their balance and gait, many were able to perform independent self-care tasks such as dressing, showering, walking up and down the driveway, and going grocery shopping. Kim Skinner, PT, DPT, Director of Physical Therapy, Helius Medical Technologies
Tori Etheridge, PoNS Treatment™ Specialist, shares her story
Sonia Brodie talks about PoNS™ patient experiences
PoNS and PoNS Treatment are trademarks of Helius Medical, Inc
PoNS™ is an authorized medical device and commercially available in Canada. PoNS™ is an investigational device in the US, EU, and Australia and is currently under review for market clearance by the AUS TGA; PoNS™ is not commercially available in the US, EU, or Australia.
The device is intended for use as a short term treatment (14 weeks) of chronic balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with physical therapy. The device is intended for use as a short term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from MS and is to be used in conjunction with physical therapy.